1. Home
  2. GWW vs INSM Comparison

GWW vs INSM Comparison

Compare GWW & INSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GWW
  • INSM
  • Stock Information
  • Founded
  • GWW 1927
  • INSM 1988
  • Country
  • GWW United States
  • INSM United States
  • Employees
  • GWW N/A
  • INSM N/A
  • Industry
  • GWW Office Equipment/Supplies/Services
  • INSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • GWW Industrials
  • INSM Health Care
  • Exchange
  • GWW Nasdaq
  • INSM Nasdaq
  • Market Cap
  • GWW 45.4B
  • INSM 41.2B
  • IPO Year
  • GWW N/A
  • INSM 2000
  • Fundamental
  • Price
  • GWW $921.05
  • INSM $203.94
  • Analyst Decision
  • GWW Hold
  • INSM Strong Buy
  • Analyst Count
  • GWW 8
  • INSM 19
  • Target Price
  • GWW $1,026.67
  • INSM $171.12
  • AVG Volume (30 Days)
  • GWW 311.2K
  • INSM 2.3M
  • Earning Date
  • GWW 10-31-2025
  • INSM 10-30-2025
  • Dividend Yield
  • GWW 0.98%
  • INSM N/A
  • EPS Growth
  • GWW N/A
  • INSM N/A
  • EPS
  • GWW 35.69
  • INSM N/A
  • Revenue
  • GWW $17,750,000,000.00
  • INSM $447,022,000.00
  • Revenue This Year
  • GWW $5.80
  • INSM $40.09
  • Revenue Next Year
  • GWW $6.06
  • INSM $129.64
  • P/E Ratio
  • GWW $25.85
  • INSM N/A
  • Revenue Growth
  • GWW 4.83
  • INSM 30.34
  • 52 Week Low
  • GWW $893.99
  • INSM $60.40
  • 52 Week High
  • GWW $1,227.44
  • INSM $205.11
  • Technical
  • Relative Strength Index (RSI)
  • GWW 34.27
  • INSM 75.96
  • Support Level
  • GWW $938.32
  • INSM $187.55
  • Resistance Level
  • GWW $953.48
  • INSM $189.31
  • Average True Range (ATR)
  • GWW 19.74
  • INSM 6.89
  • MACD
  • GWW -3.76
  • INSM 0.62
  • Stochastic Oscillator
  • GWW 17.39
  • INSM 95.14

About GWW W.W. Grainger Inc.

Founded in 1927, W.W. Grainger originally distributed various motors via a mail-order catalogue. Over the course of the 20th century, the firm expanded into new industrial product categories and launched its first digital catalogue in 1995. Today, the company organizes itself into two segments focused on different customer bases. Its larger segment, high-touch solutions, offers a vast array of maintenance, repair, and operations, or MRO, supplies and bespoke inventory management services to larger businesses. Its smaller segment, endless assortment, operates two online platforms, Zoro and MonotaRO, that offer comprehensive catalogues of MRO supplies to smaller businesses. Grainger has operations throughout the world but primarily generates sales within the US.

About INSM Insmed Incorporated

Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the United States for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.

Share on Social Networks: